NPI: 1396204921 · LAKE HAVASU CITY, AZ 86403 · Addiction (Substance Use Disorder) Counselor · NPI assigned 03/13/2019
Authorized official GAITHER, CINDY controls 20+ related entities in our dataset. Read more
| Authorized Official | GAITHER, CINDY (VP REVENUE CYCLE MGMT) |
| NPI Enumeration Date | 03/13/2019 |
Other providers sharing the same authorized official: GAITHER, CINDY
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 8,541 | $132K |
| 2020 | 41,305 | $663K |
| 2021 | 48,659 | $772K |
| 2022 | 55,056 | $1.00M |
| 2023 | 56,409 | $1.07M |
| 2024 | 49,412 | $965K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| H2010 | Comprehensive medication services, per 15 minutes | 106,463 | 11,809 | $1.65M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 10,483 | 7,759 | $657K |
| T1016 | Case management, each 15 minutes | 24,603 | 7,099 | $510K |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 9,394 | 465 | $396K |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 79,583 | 9,155 | $340K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,157 | 3,435 | $340K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 6,705 | 5,215 | $225K |
| H0031 | Mental health assessment, by non-physician | 1,094 | 1,058 | $196K |
| T1002 | Rn services, up to 15 minutes | 4,513 | 3,180 | $109K |
| T1003 | Lpn/lvn services, up to 15 minutes | 3,584 | 2,341 | $63K |
| H0038 | Self-help/peer services, per 15 minutes | 2,283 | 1,394 | $44K |
| H0033 | Oral medication administration, direct observation | 2,308 | 329 | $38K |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 3,018 | 169 | $27K |
| H0023 | Behavioral health outreach service (planned approach to reach a targeted population) | 527 | 191 | $6K |
| J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine | 332 | 24 | $5K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 41 | 41 | $1K |
| 80305 | 237 | 174 | $1K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 57 | 46 | $1K |